Scholarlink

Objective <p>To quantify midazolam (MID) and dexmedetomidine (DEX) exposure in preterm infants with chronic respiratory failure (CRF) due to severe bronchopulmonary dysplasia (sBPD) and assess associations with Behavioral Signs of Respiratory Instability (BSRI) scores.</p> Study design <p>Infants born &lt;32 weeks’ gestation with sBPD requiring tracheostomy and chronic ventilation were included. Daily MID and DEX exposure was quantified from NICU admission until discharge, death, or transfer. Multivariable mixed-effects models evaluated associations between medication exposure and weekly BSRI scores, adjusting for selected confounders.</p> Results <p>Among 40 infants (median NICU stay: 202 days), median exposures were 4.4 weeks for DEX and 2 weeks for MID, with peak doses surrounding tracheostomy. Medication exposure was not independently associated with BSRI scores. Higher respiratory severity scores correlated with increased medication doses.</p> Conclusion <p>Neurosedative medication dosing correlated with disease severity. These findings highlight the need to optimize dosing strategies and neurodevelopmental outcomes in this vulnerable population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dexmedetomidine and midazolam usage and association with BSRI scores in preterm infants with chronic respiratory failure

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月23日

查看全文
  • John Mascari,
  • Spencer Millen,
  • Tanvi Batish,
  • Karol Suarez,
  • Susan Slattery,
  • Megan Lagoski,
  • Natalia Henner,
  • Janice Raucci,
  • Nicolas Porta,
  • Karna Murthy

摘要

Objective

To quantify midazolam (MID) and dexmedetomidine (DEX) exposure in preterm infants with chronic respiratory failure (CRF) due to severe bronchopulmonary dysplasia (sBPD) and assess associations with Behavioral Signs of Respiratory Instability (BSRI) scores.

Study design

Infants born <32 weeks’ gestation with sBPD requiring tracheostomy and chronic ventilation were included. Daily MID and DEX exposure was quantified from NICU admission until discharge, death, or transfer. Multivariable mixed-effects models evaluated associations between medication exposure and weekly BSRI scores, adjusting for selected confounders.

Results

Among 40 infants (median NICU stay: 202 days), median exposures were 4.4 weeks for DEX and 2 weeks for MID, with peak doses surrounding tracheostomy. Medication exposure was not independently associated with BSRI scores. Higher respiratory severity scores correlated with increased medication doses.

Conclusion

Neurosedative medication dosing correlated with disease severity. These findings highlight the need to optimize dosing strategies and neurodevelopmental outcomes in this vulnerable population.